Clinical Trial Update: Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity [NA]

View source ↗

Summary

Vitamin D supplementation in individuals with obesity reduces renin-angiotensin system activity, suggesting a potential impact on hypertension risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity
• Vitamin Deficiency

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Obesity, Vitamin D Deficiency | NA | Status: COMPLETED | Results posted: 2017-02-14